ChinaBio® Partnering Forum Content
Prepare for your partnering experience with the most accurate and up-to-date information on China life sciences.
State of China Life Science – 2020 H1
Unlock the most up-to-date data and insights into China’s record-setting investments in the life science sector when you read this exclusive report from ChinaBio®. Discover how VC, IPO, and Partnering have rebounded despite COVID-19, but how M&A continues to slump.
Keynote: State of China Life Science – 2020 H1. Back on Track: VC, Partnering and IPOs Rebound.
This special report by Greg B. Scott, Founder & CEO of ChinaBio(R) provides an in-depth analysis of investments, BD activities, and IPO trends. This highly anticipated report sets the stage for the following live plenary session which features executives from leading MNC's, and provides the backdrop for many of the pre-recorded panels.
Johnson & Johnson’s approach to external innovation
William N. Hait, MD, PhD, Global Head at Johnson & Johnson External Innovation, gives an exclusive interview to Lucie Ellis, Executive Editor of In Vivo, Pharma Intelligence. Watch to learn how partners complement J&J innovation, how digital health, artificial intelligence, and machine learning fit into their strategy, and the details regarding the company’s presence in China.
Top Biotech Deals in China
Discover the deals transforming China biotech. More than $12 billion in biopharma financing, alliances, IPOs, and new funds have been generated so far this year in China. Learn the details of these deals when you read this new infographic.
J&J’s multi-pronged approach to life science innovation, partnerships, and advanced technologies
Dr. Dan Wang, Head, Johnson & Johnson Innovation, Asia Pacific, and Dr. Sharon Chan, Head of JLABS @ Shanghai discuss its support of startups, interests in diverse disease areas, the importance of collaborations and much more in this exclusive interview with EBD Group.
Roche’s approach to drug discovery, innovation and meeting patients' needs
In an exclusive interview James Sabry, Global Head of Roche Pharma Partnering, discusses Roche’s approach to discovering scientific breakthroughs, accelerating innovative research, collaborating with stakeholders, and meeting unmet medical needs in China and around the world.
China's Challenges in the Wake of COVID-19
Gain a rare peek into the policies behind the vaccines race in China and the impact COVID-19 has had on its pharmaceutical supply chains, plus much more in this exclusive article pack from Pharma Intelligence.